Vedabio

Vedabio company information, Employees & Contact Information

Explore related pages

Related company profiles:

Veda is derived from the Sanskrit word for the creation of knowledge. With our team of industry leading experts, we operate at the forefront of scientific innovation to push the limits of what’s possible in the field of molecular detection. VedaBio is unlocking a universe of possibilities in molecular biology with a breakthrough platform for near-instant molecular detection of highly multiplexed analytes, delivering best-in-class accuracy without the need for target amplification.
Looking for a particular Vedabio employee's phone or email?

Vedabio Questions

News

VedaBio Announces Strategic Agreement with Siemens Healthineers and Series A Extension, Totaling Up to $25 Million - Yahoo Finance

VedaBio Announces Strategic Agreement with Siemens Healthineers and Series A Extension, Totaling Up to $25 Million Yahoo Finance

VedaBio Partners with Mammoth Biosciences to Enhance CRISPR-Based Diagnostics - SynBioBeta

VedaBio Partners with Mammoth Biosciences to Enhance CRISPR-Based Diagnostics SynBioBeta

VedaBio Expands CRISPR-Based Molecular Detection Platform With Mammoth Biosciences’ Technology - Business Wire

VedaBio Expands CRISPR-Based Molecular Detection Platform With Mammoth Biosciences’ Technology Business Wire

VedaBio Appoints Rachel Jones as Chief Commercial Officer - Business Wire

VedaBio Appoints Rachel Jones as Chief Commercial Officer Business Wire

VedaBio and Mammoth Biosciences partner to enhance CRISPR diagnostic solutions - Medical Device Network

VedaBio and Mammoth Biosciences partner to enhance CRISPR diagnostic solutions Medical Device Network

VedaBio: Significant Funding Secured And Strategic Partnership Signed Advance Molecular Diagnostics - Pulse 2.0

VedaBio: Significant Funding Secured And Strategic Partnership Signed Advance Molecular Diagnostics Pulse 2.0

Siemens Healthineers enters CRISPR diagnostics space - European Biotechnology Magazine

Siemens Healthineers enters CRISPR diagnostics space European Biotechnology Magazine

VedaBio Expands CRISPR-Based Molecular Detection Platform - Medical Product Outsourcing

VedaBio Expands CRISPR-Based Molecular Detection Platform Medical Product Outsourcing

VedaBio to use Mammoth Biosciences’ CRISPR-based technology for diagnostic applications - Indian Pharma Post

VedaBio to use Mammoth Biosciences’ CRISPR-based technology for diagnostic applications Indian Pharma Post

New CRISPR diagnostic player VedaBio emerges with $40M start - Fierce Biotech

New CRISPR diagnostic player VedaBio emerges with $40M start Fierce Biotech

VedaBio emerges from stealth with $40m for CRISPR-driven molecular detection - Medical Device Network

VedaBio emerges from stealth with $40m for CRISPR-driven molecular detection Medical Device Network

VedaBio Launches with Over $40 Million to Revolutionize Molecular Detection - Business Wire

VedaBio Launches with Over $40 Million to Revolutionize Molecular Detection Business Wire

VedaBio Appoints Randy Rasmussen, Former CEO of BioFire Diagnostics, to Board of Directors - Business Wire

VedaBio Appoints Randy Rasmussen, Former CEO of BioFire Diagnostics, to Board of Directors Business Wire

VedaBio Appoints Dr. G. Brett Robb as Senior Scientific Director and Head of CRISPR Science - Business Wire

VedaBio Appoints Dr. G. Brett Robb as Senior Scientific Director and Head of CRISPR Science Business Wire

Top Vedabio Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant